Stocksigma LogoStocksigma Logo

Dr. Reddy’s Partners with Takeda for Dengue Vaccine Distribution in India

Dr. Reddy's Laboratories entered into an exclusive agreement on 18th Sep'26 with Takeda Biopharmaceuticals India to distribute and market Qdenga®, India’s

Dr. Reddy’s Partners with Takeda for Dengue Vaccine Distribution in India

Dr Reddys Laboratories Ltd · Press Release · 18 Sept 2026, 2:30 pm

Dr. Reddy’s Partners with Takeda for Dengue Vaccine Distribution in India Dr. Reddy's Laboratories entered into an exclusive agreement on 18th Sep'26 with Takeda Biopharmaceuticals India to distribute and market Qdenga®, India’s first CDSCO-approved dengue vaccine, across the domestic private market for individuals aged 4–60 years. Takeda will handle manufacturing, importation, and public market rights, retaining legal ownership. The agreement entails no upfront consideration or milestone payments. The vaccine is anticipated to launch in H1'27, strengthening Dr. Reddy's domestic vaccines portfolio amid rising dengue prevalence.

Original exchange filing (PDF)

More announcements from Dr Reddys Laboratories Ltd

All Dr Reddys Laboratories Ltd announcements